Colleen Olive
Cooperative Research Centre for Vaccine Technology
The Queensland Institute of Medical Research
PO Royal Brisbane Hospital
Brisbane
Australia
Name/email consistency: high
- Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. Olive, C., Ho, M.F., Dyer, J., Lincoln, D., Barozzi, N., Toth, I., Good, M.F. J. Infect. Dis. (2006)
- Intranasal administration is an effective mucosal vaccine delivery route for self-adjuvanting lipid core peptides targeting the group A streptococcal M protein. Olive, C., Sun, H.K., Ho, M.F., Dyer, J., Horváth, A., Toth, I., Good, M.F. J. Infect. Dis. (2006)
- Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides. Olive, C., Hsien, K., Horváth, A., Clair, T., Yarwood, P., Toth, I., Good, M.F. Vaccine (2005)
- Lipid core peptide technology and group A streptococcal vaccine delivery. Olive, C., Batzloff, M.R., Toth, I. Expert. Rev. Vaccines (2004)
- Group A streptococcal vaccine delivery by immunization with a self-adjuvanting M protein-based lipid core peptide construct. Olive, C., Batzloff, M., Horváth, A., Clair, T., Yarwood, P., Toth, I., Good, M.F. Indian J. Med. Res. (2004)
- Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens. Olive, C., Batzloff, M., Horváth, A., Clair, T., Yarwood, P., Toth, I., Good, M.F. Infect. Immun. (2003)
- Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope. Olive, C., Clair, T., Yarwood, P., Good, M.F. Vaccine (2002)
